NCT01160380 - A Study of the Effectiveness of Armodafinil to Treat Cancer-Related Fatigue in Patients With Multiple Myeloma | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 30, 2010

Primary Completion Date

June 30, 2013

Study Completion Date

May 31, 2014

Conditions

FatigueMultiple Myeloma

Interventions

DRUG

armodafinil

Armodafinil taken at 150 mg daily. Taken as three 50 mg tablets.

DRUG

Placebo

Placebo taken at 150 mg daily. Taken orally as three 50 mg tablets.

Trial Locations (3)

James R. Berenson, MD, Inc., West Hollywood

Michael J. Schlutz, M.D., Inc, Newport Beach

Pacific Cancer Medical Center, Inc., Anaheim